BusinessWeek looks at how Big Pharma influenced Medscape’s CME offerings.
This story was originally broken by psychiatrist Daniel Carlat, in another example where physician bloggers can tip off mainstream media.
Related posts:
- How much can Medscape be bought for?
- Medscape under fire
- MGH psychiatrists in trouble
- Who’s Daniel Carlat targeting next?
- Drug companies in cahoots with medical journals?
- Commercial CME
- Daniel Carlat pays a visit
KevinMD.com on Facebook
{ 1 comment }
That’s why I say there should be no restrictions on what pharma gives to individual physicians. Stop them from giving to physicians, all they do is go higher up the food chain. To CME like Medscape, and eventually to hospital administrators. When the pharma money makes it to the hospital administrators, there will be more corruption in a week than all the AMA could even conceive of doing in a century.
Comments on this entry are closed.